Krm Ayurveda Ipo
KRM Ayurveda IPO Review & Key Points
Review: May Apply
IPO Lead Managers aka Merchant Bankers
NEXGEN Financial Solutions Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,70,000 |
| Retail Maximum | 2 | 2,000 | ₹2,70,000 |
| S-HNI Minimum | 3 | 3,000 | ₹4,05,000 |
| S-HNI Maximum | 7 | 7,000 | ₹9,45,000 |
| B-HNI Minimum | 8 | 8,000 | ₹10,80,000 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | 15,42,000 Shares | 26.86% |
| QIB (Ex. Anchor) | 10,32,000 Shares | 17.98% |
| NII Shares Offered | 7,80,000 Shares | 13.59% |
| Retail Shares Offered | 18,12,000 Shares | 31.57% |
| Anchor Bidding Date | January 20, 2026 |
| Anchor Investors List | |
| Shares Offered | 15,42,000 Shares |
| Anchor Size | 20.82 Cr. |
| lock-in period end date 50% shares (30 Days) | February 26, 2026 |
| lock-in period end date 50% shares (90 Days) | April 27, 2026 |
| IPO Open Date: | January 21, 2026 |
| IPO Close Date: | January 23, 2026 |
| Basis of Allotment: | January 27, 2026 |
| Refunds: | January 28, 2026 |
| Credit to Demat Account: | January 28, 2026 |
| IPO Listing Date: | January 29, 2026 |
| IPO Bidding Cut-off Time: | January 23, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 1,55,20,800 | 92.16% |
| Promoter Holding Post Issue | 2,12,60,800 | 67.28% |
| Purpose | Crores |
| Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | ₹13.67 |
| Purchase of CRM Software and Hardware Infrastructure | ₹1.42 |
| Human Resources | ₹5.44 |
| Repayment/Prepayment of loan | ₹12.50 |
| Working Capital Requirement | ₹18.00 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹89.38 | ₹79.29 | ₹7.60 | ₹39.48 |
| 2024 | ₹67.57 | ₹62.85 | ₹3.41 | ₹43.91 |
| 2025 | ₹76.95 | ₹60.61 | ₹12.10 | ₹66.79 |
| Sep 2025 | ₹48.65 | ₹37.65 | ₹8.14 | ₹78.12 |
| KPI | Values |
| ROE: | 67.86% |
| ROCE: | 43.33% |
| EBITDA Margin: | 24.96% |
| PAT Margin: | 15.80% |
| Debt to equity ratio: | 1.31 |
| Earning Per Share (EPS): | ₹8.06 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 67.86% |
| Net Asset Value (NAV): | ₹1,602.40 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Jeena Sikho Lifecare Ltd. | 8.86 | 76.58 | 31.28% | 142.24 | 110.10 Cr. |
| Vaidya Sane Ayurved Laboratories Ltd | 3.07 | 93.20 | 5.12% | 59.85 | 3.22 Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date | January 21, 2026 |
| IPO Close Date | January 23, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹128 to ₹135 Per Share |
| Issue Size | Approx ₹77.49 Crores |
| Fresh Issue | Approx ₹77.49 Crores |
| Issue Type | Book Build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |